-
AstraZeneca Pharmaceuticals LP et al v. Teva Pharmaceuticals USA DC CAFC
- 1:08-cv-00426
- D. Del.
- Judge: Joseph J. Farnan, Jr
- Filed: 07/10/2008
- Closed: 07/13/2010
- Latest Docket Entry: 10/17/2013
- PACER
- Docket updated daily
4
Plaintiffs
1
Defendant
1
Accused
Product
1
Patent-in-Suit
734
Days in
Litigation
-
AstraZeneca Pharmaceuticals LP et al v. Teva Pharmaceuticals USA DC CAFC
- 1:08-cv-00426
- D. Del.
- Judge: Joseph J. Farnan, Jr
- Filed: 07/10/2008
- Closed: 07/13/2010
- Latest Docket Entry: 10/17/2013
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 6 |
<INS-S DATE="20010807" ID="INS-S-00002">6. The compound
view more
|
Enforceable and Valid (103)
Entry 254 |
| 8 |
<INS-S DATE="20010807" ID="INS-S-00004">8. The compound of claim <HIL><BOLD>6</BOLD></HIL> in the form of a calcium salt.<INS-E ID="INS-S-00004">
|
Enforceable and Valid (103)
Entry 254 |
-
Infringement
Teva Pharmaceuticals USA, Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic Crestor | US RE37,314 E1 |
6, 8
|
Infringement
Entry 262Entry 260 Entry 254 |
